|
TSHA Taysha Gene Therapies Inc 1806310 |
| Balance Sheet |
|
Current Assets
|
142,130,000 |
|
Assets
|
160,364,000 |
|
Current Liabilities
|
26,227,000 |
|
Liabilities
|
88,839,000 |
|
Equity
|
71,525,000 |
|
Shares Out
|
204,943,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-81,225,000 |
|
Investing Cash Flow
|
-363,000 |
| Market Analysis |
Market Cap
|
412,960,770 |
|
Price
|
1.82 |
|
BVPS
|
0.35 |
|
PB
|
5.13 |
|
EPS
|
-0.90 |
|
PS
|
12.39 |
|
FCF
|
-81,588,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/26 |
-0.36 |
3/19 |
0.83 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TSHA documents filed with the SEC.
TSHA Filings
Clear
